Skip to main content
Search
Search This Blog
Biopharma Over Coffee
Updates on recent goings on in the pharma, biotech and healthcare sectors.
Posts
Showing posts with the label
drug pricing
Show all
February 12, 2026
MFN Pricing and the “Global Launch Freeze”: A More Measured Perspective
December 08, 2025
NICE, VPAG and the UK’s new signal to pharma: Progress at last
September 19, 2025
MASH in 2025: New Therapies, New Challenges
August 07, 2025
China’s NRDL: The World’s Largest Market Access Event Is Underway
July 02, 2025
GLP-1s and the Rise of Consumer-Led Pharma: What the Obesity Market Signals for the Future of Access
May 22, 2025
Most-Favored-Nation Drug Pricing: Policy Shift or Pressure Tactic?
May 05, 2025
Trump’s Drug Pricing Executive Order: Uncertainty for Pharma Leaders
Older Posts
Home
